Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe only legal route to a semaglutide pen in the UK is a prescription, issued after a clinical assessment by a registered prescriber. Wegovy — the brand licensed here for weight management — is a prescription-only medicine, and no legitimate seller can hand one over without that step. What that process looks like in practice, and how to be certain the pharmacy you choose is the real thing, is what this page covers. If you've heard that some sites sell semaglutide pens without going through a prescriber, the MHRA has been clear: those supplies fall outside the licensed UK route and carry serious risks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's appraisal of semaglutide 2.4mg (Wegovy) for weight management set a clear clinical framework: it recommended the treatment for eligible adults within a specialist weight management service, for a maximum of two years, alongside structured diet and activity support. The STEP 1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. Those figures shaped both the NICE recommendation and the eligibility thresholds that any responsible prescriber now applies.
One misconception worth gently letting go: some people assume that because Ozempic contains the same active ingredient, it can serve the same purpose. It can't, legally. Ozempic is licensed for type 2 diabetes; Wegovy is the weight-management licence. A prescriber following UK guidance will always work within the correct licensed indication.
More recently, the MHRA approved a higher 7.2mg maintenance dose and, on 14 April 2026, a dedicated single-dose 7.2mg pen, expanding the options available within the Wegovy licence. Whether a specific dose or pen format is right for you is a clinical question, confirmed at consultation, not at checkout.
A legitimate prescription journey has a predictable shape. You complete a clinical questionnaire, medical history, current medications, weight, relevant conditions. A registered prescriber reads it. If you meet the licensed criteria and there are no contraindications, a prescription is issued. The pharmacy then dispenses and ships. At nume, a GPhC-registered Independent Prescriber personally reviews every consultation the same working day. There is no algorithm making that call.
After that, the consultation process includes photo-ID identity verification and live weight confirmation on video, steps that exist because the MHRA has documented real harm from fake pens reaching people who had no clinical oversight at all. Those aren't bureaucratic boxes. They are the checks that make the supply chain traceable.
Repeat orders follow the same pattern: a clinical re-review before every prescription, with evidence required for dose increases. No prescription auto-renews at nume. That means a prescriber has seen your case before every single pen is dispensed.
Every pharmacy legally operating in the UK must be registered with the GPhC. You can check any provider (including us) on the GPhC register directly; our premises registration number is 9012878. If a site isn't listed, stop there.
The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online and via social media, with enforcement escalating sharply through 2025, around 20 million doses of illegally traded weight-loss medicines, valued at roughly £45 million, were seized. Some fake pens have contained insulin rather than semaglutide, with serious consequences for the people who used them. Prices far below market rate, sellers operating without requiring a prescription, and discount codes for prescription medicines are the clearest red flags. You can report a suspicious seller through the MHRA Yellow Card scheme.
Sourcing a genuine Wegovy pen through the licensed UK supply chain, from a pharmacy you can verify, is the baseline. Everything else is a variable you cannot control.
The licensed eligibility for Wegovy covers adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't determine the outcome, the prescriber considers the full picture, including medicines you already take and any contraindications.
NHS access to Wegovy is currently available through specialist weight management services under NICE's appraisal TA875, but waiting lists are commonly long and the criteria are strict. The NHS route for semaglutide is worth understanding if you want to explore it, but it isn't the only option. Private treatment through a regulated online pharmacy doesn't require a referral or a wait. It does require the same clinical assessment, because the medicine is the same and the prescription requirement doesn't change based on who's paying.
If you want to understand current semaglutide availability in the UK before starting, or read more about how Wegovy works, those pages will give you a clearer picture. When you're ready, speak to our prescribers, there's no charge for the consultation, and you're not committed to anything until a prescription is issued. If you are also researching the research-grade market, our guide to buying semaglutide peptide in the UK explains how that differs from the licensed medicine and what the regulations mean in practice.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.